Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies

Published by Business Insights
Table of contentsBrochure | Order form
Pages: 143, Coverage: Global, Published: April 2009
Single user copy: $3,835

The pharmaceutical contract manufacturing (PCM) industry continues to grow at a steady pace, driven by cost pressures, stringent regulatory requirements and patent expiries. The highly competitive nature of the industry has been driving consolidation and companies are increasingly offshoring to emerging markets to reduce costs. As a result, players in key outsourcing destinations have been improving their manufacturing infrastructure to increasing their global competitiveness.

‘Key Players in Pharmaceutical Contract Manufacturing’ is a new report published by Business Insights that examines the competitive landscape of the global PCM industry. The latest key issues and developments in the contract manufacturing market are identified and leading companies in this sector are profiled in detail. For each of the top 10 CMO companies, this report provides a detailed examination of financial performance by business segment, manufacturing and R&D capacity, growth strategies and key acquisitions/divestments. This report also examines the size and growth of the global CMO industry, with analysis of major market drivers and trends in CMO destinations.

Use this report to:

  • Compare the performances of the top 10 CMO companies across key business segments with this report’s analysis of Catalent, Lonza, Boehringer Ingelheim (BI), DSM, Patheon, Evonik, Piramal, Jubilant, Aenova, Fareva.
  • Identify the market dynamics of the global PCM industry over the 2003-07 period, discover which emerging markets are becoming the CMO destinations of the future and understand the major issues affecting key industry players.
  • Assess the future prospects of the top 10 CMO companies with this report’s analysis of each firm’s manufacturing and R&D capability, growth strategies and M&A activity.
  • Measure the progress of other leading CMO companies by evaluating the financial performances of Nipro, Siegfried, Haupt, Divi’s Laboratories (Divi’s), Cambrex, Recipharm, Archimica, Vetter, Famar and NextPharma.

Our Guarantee of Quality and Value
We stand 100% behind the quality and value of our products. If you are dissatisfied, simply let us know and we will send you an immediate refund for your entire order – no questions asked.


Click here for a printable order form that you can fax or mail at a later time.



Email address:
You'll also receive info on upcoming audioconferences and other tech transfer related products.
or click here for more options...